Lymphocyte Mitogen Response Assays Form

Chat with GenHealth to automate any policy or prior auth task.


Lymphocyte Mitogen Response Assay

Indications

(608510) Is the Lymphocyte Mitogen Response Assay performed to assess lymphocytic function in a patient with a diagnosed immunodeficiency disease? 
(608511) Is the Lymphocyte Mitogen Response Assay performed to monitor immunotherapy in the patient? 

Contraindications

(608512) Is the Lymphocyte Mitogen Response Assay used to monitor the treatment of cancer in the patient? 
Effective Date

05/16/1983

Last Reviewed

NA

Original Document

  Reference



Background for this Policy

The lymphocyte mitogen response assay measures the immune response of patient peripheral blood lymphocytes.

It is a covered test under Medicare when it is medically necessary to assess lymphocytic function in diagnosed immunodeficiency diseases and to monitor immunotherapy.

It is not covered when it is used to monitor the treatment of cancer, because its use for that purpose is experimental.

Book a walkthrough

Walk through this policy with us

Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.